Clinical Trials Logo

Chronic Obstructive Pulmonary Disease clinical trials

View clinical trials related to Chronic Obstructive Pulmonary Disease.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06460493 Recruiting - COPD Clinical Trials

Effect of Ensifentrine Treatment on CAT Score

Start date: June 11, 2024
Phase: Phase 3
Study type: Interventional

This is an open-label study at one study center that will assess the effect of twice-daily nebulized ensifentrine on COPD Assessment Test (CAT™) scores over 12 weeks in subjects with moderate to severe COPD. Subjects will continue their long-acting dual or triple COPD maintenance treatments during study participation.

NCT ID: NCT06459843 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Effects Of of Pursed Lip Breathing and Coordinated Breathing in Adult Patients With COPD

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

COPD is the chronic lung condition characterized by the damage and enlargement of the air sacs in the lungs, leading to breathing difficulties. A blockage may develop, which traps air inside your lungs. The patient shows clinical manifestation of cough, wheezing, chest tightness, shortness of breath. This research of randomized clinical trial will check the combined effects of pursed lip breathing and coordinated breathing techniques to improve aerobic capacity and dyspnea in patients with COPD by taking sample of 54 patients through convenience sampling and randomly allocating them to two groups A and B out of which A will receive pursed lip breathing with aerobic exercise for 4 times per week for 4 week and duration will be 45-60 min, B will receive coordinated breathing with aerobic exercise for 4 times per week for 4 weeks. And duration will be 45-60 min.Pre and post training outcomes of aerobic capacity and dyspnea will be measured through Six minute walk test and dyspnea Borg scale, and Saint George respiratory questionnaire. The data will be analyzed through SPSS 21.

NCT ID: NCT06442059 Recruiting - COPD Clinical Trials

Clinical Variables and Dyspnea and Fear of Movement in Chronic Obstructive Pulmonary Patients

Start date: October 1, 2023
Phase:
Study type: Observational

Patients diagnosed with COPD who applied to the Pulmonary Diseases Department of Kırıkkale Yüksek İhtisas Hospital will be included in the study. The aim of our study: It is aimed to investigate the effect of fear of movement due to dyspnea on respiratory function, muscle strength, physical performance and balance in Chronic Obstructive Pulmonary Disease Patients.

NCT ID: NCT06436482 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Research of Endobronchial Optical Coherence Tomography in Pre-COPD

EBOCTIPCOPD
Start date: March 1, 2023
Phase:
Study type: Observational

The pre-stage of Chronic Obstructive Pulmonary Disease (Pre-COPD) is challenging to diagnose. However, identifying Pre-COPD is a crucial step in the prevention and management of COPD. Endobronchial optical coherence tomography showed the value of diagnosis in Pre-COPD and COPD in previous researchs.

NCT ID: NCT06434792 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease

Start date: June 1, 2023
Phase: Phase 2
Study type: Interventional

This clinical trial is a multicenter, randomized, double-blind, placebo-controlled, parallel-group dose-response phase 2 clinical trial study to evaluate the efficacy and safety of Bronpass Tab. in 96 patients with chronic obstructive pulmonary disease.

NCT ID: NCT06432972 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Accelerated Pulmonary Rehabilitation in the Preoperative Period

PREHAB
Start date: January 2, 2024
Phase: N/A
Study type: Interventional

This proposed project will be a single arm, non-masked study. Participants who are actively smoking with a diagnosis of COPD and new lung nodule, either confirmed or suspicious for lung cancer, with a plan for surgical resection will be recruited from the University of Vermont Medical Center (UVMMC) Lung Multidisciplinary Clinic (LMDC). All patients will be enrolled in prehab and offered smoking cessation therapy. The acceptability and feasibility of this intervention will be measured by percent enrollment in study, attendance, barriers to completion, and monitoring of adverse events. The effect of prehab will be measured by traditional metrics, including fitness, respiratory symptoms, and depression scale. Research outcomes will be measured by smoking habits, anxiety, and surgical complications. Investigators estimate that 20 participants over a two-year period will be sufficient to measure the safety and feasibility of this study. Investigators aim to enroll, on average, 2 participants per month in order to complete this study in a timely fashion. Participants will be enrolled in prehab on a rolling basis, as to not delay surgical timeline.

NCT ID: NCT06428513 Recruiting - Copd Clinical Trials

Health Coaching Telemedicine Program for Lung Transplant Candidates With End-stage Lung Disease.

HCTP
Start date: November 19, 2023
Phase: N/A
Study type: Interventional

Lung transplantation has become standard of care for selected patients with end stage pulmonary disease. While on the lung transplantation waiting list, patient health, emotional wellbeing and quality of life can deteriorate. By improving or changing patient physical activity, healthy nutrition, tobacco cessation, patient preparation for lung transplantation can be optimized, risk of complications can be reduced, and outcomes post transplantation can be improved. The potential of health coaching to improve health outcomes has been demonstrated in several chronic diseases such as type 2 diabetes mellitus, congestive heart failure, and rheumatoid arthritis. In addition, health coaching was proven effective through telemedicine. No studies so far have addressed the potential effect of a pre-transplant health coaching program on existing medical conditions, transplant rates and post-transplant outcomes. Investigators hypothesized that health coaching can improve health outcomes and survival of lung transplantation candidates by supporting and growing patients' capacity to cope with the demands of their end stage pulmonary disease.

NCT ID: NCT06422676 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

MultIceNtre Non-intERVentional Study for Efficacy,Safety Evaluation of BREZTRI in Pts With COPD in RussiA

MINERVA
Start date: December 29, 2023
Phase:
Study type: Observational

This is a retrospective-prospective, non-interventional, multi-centre study that will be conducted in routine clinical settings in Russia. Eligible patients with moderate to severe COPD routinely treated with BREZTRI will be observed according to routine clinical practice for up to 24 weeks.

NCT ID: NCT06421896 Recruiting - COPD Clinical Trials

Motivational Enhancement Therapy's Impact on d COPD Outcomes in Geriatric Patient

METgeriatri
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

Motivational Enhancement Therapy (MET) is a systematic intervention that focuses on eliciting and strengthening a person's intrinsic motivation to change. MET is rooted in motivational interviewing principles, emphasizing empathy, autonomy, and the evocation of the patient's own motivations for change. The therapy typically involves several sessions where therapists help patients identify personal goals, explore ambivalence towards change, and develop actionable plans to achieve their desired outcomes.

NCT ID: NCT06410950 Recruiting - Copd Clinical Trials

Mechanical Muscle Proprieties in Patient With COPD

Start date: May 13, 2024
Phase:
Study type: Observational

This study aims to determine if patients with Chronic Obstructive Pulmonary Disease (COPD) exhibit altered muscle properties (specifically changes in tone and stiffness) in both their respiratory muscles and skeletal muscles when compared to healthy individuals. The study will utilize the Myotonometer, a non-invasive device, to assess these properties.